While an average of 221 Americans died from an opioid overdose every single day in 2021, the crisis is a complex and deeply human tragedy whose true scale is revealed through a cascade of startling statistics that trace its devastating path from prescriptions to loss.
Key Takeaways
- In 2021, there were 80,411 drug overdose deaths involving opioids in the United States, a 22% increase from 2020.
- Synthetic opioids other than methadone (primarily fentanyl) were involved in 71,238 overdose deaths in 2021, accounting for 88% of all opioid-involved overdose deaths.
- From 1999 to 2021, nearly 645,000 people died from an overdose involving any opioid, including prescription and illicit opioids as well as heroin and fentanyl.
- In 2019, 10.1 million people aged 12 or older misused prescription opioids in the past year in the US.
- Past-year prescription opioid misuse among adults aged 18-25 was 3.8% in 2020, equating to 1.2 million people.
- In 2021, 5.6 million people aged 12+ used prescription pain relievers for nonmedical purposes in the past year.
- Males had a 1.8% past-year prescription opioid misuse rate vs 1.4% for females in 2021.
- Non-Hispanic Whites had 2.2% past-year opioid misuse rate in 2021, highest among races.
- Adults aged 18-25 had the highest opioid use disorder rate at 3.1% in 2021.
- The annual economic cost of opioid crisis in US was $1.02 trillion in 2017.
- Opioid misuse cost employers $44.7 billion in absenteeism in 2018.
- Healthcare costs for opioid use disorder reached $35.4 billion in 2017.
- In 2020, only 13.5% of people with OUD received medications for OUD (MOUD).
- Buprenorphine treatment retention averaged 50% at 6 months in 2021 studies.
- Methadone maintenance reduced overdose risk by 59% per meta-analysis.
Opioid overdose deaths tragically rose again last year, driven by dangerous fentanyl.
Demographics
1Males had a 1.8% past-year prescription opioid misuse rate vs 1.4% for females in 2021.
Verified2Non-Hispanic Whites had 2.2% past-year opioid misuse rate in 2021, highest among races.
Verified3Adults aged 18-25 had the highest opioid use disorder rate at 3.1% in 2021.
Verified4Opioid overdose death rates were highest in ages 25-44 at 38.5 per 100,000 in 2021.
Directional5American Indian/Alaska Natives had opioid overdose rate of 28.6 per 100,000 in 2021.
Single source6Males accounted for 69% of opioid overdose deaths in 2021.
Verified7In Appalachia, opioid prescribing rates were 1.5 times national average in 2019.
Verified8Black Americans' opioid death rate increased 44% from 2019-2020.
Verified9Women aged 25-44 saw opioid misuse rates double from 2002-2012.
Directional10Among US adults with chronic pain, 8% of women vs 7% men misused opioids in 2019.
Single source11Hispanic adults had 1.5% opioid use disorder rate in 2021.
Verified12Rural residents had 50% higher opioid hospitalization rates than urban in 2019.
Verified13Veterans represented 11% of opioid prescriptions despite being 7% of population.
Verified14Pregnant women with opioid use disorder increased 4-fold from 1999-2014.
Directional15Among incarcerated, 50% had opioid use disorder history in 2020 survey.
Single source16LGBTQ+ youth had 2x higher opioid misuse rates than heterosexual peers.
Verified17Low-income adults (<$25k) had 3.5% misuse rate vs 0.8% high-income in 2021.
Verified18College non-graduates had 2.5x higher opioid death rates than graduates.
Verified19In 2021, 40% of opioid deaths were among those under 35 years old.
Directional20Black males aged 25-34 had opioid death rate of 65.9 per 100,000 in 2021.
Single source21Among Native Hawaiians/Pacific Islanders, misuse rate was 2.8% in 2021.
Verified2225% of opioid misusers were employed full-time in 2019 NSDUH.
VerifiedDemographics Interpretation
The statistics paint a grim portrait of a national crisis where disparities in age, race, gender, geography, and socioeconomic status do not merely correlate with opioid abuse but actively conspire to determine who suffers and who dies.
Economic Costs
1The annual economic cost of opioid crisis in US was $1.02 trillion in 2017.
Verified2Opioid misuse cost employers $44.7 billion in absenteeism in 2018.
Verified3Healthcare costs for opioid use disorder reached $35.4 billion in 2017.
Verified4Criminal justice costs from opioids totaled $72.5 billion annually in 2017.
Directional5Lost productivity from premature deaths cost $504 billion from 2001-2017.
Single source6Opioid-related healthcare spending increased 72% from 2013-2019 to $17.7B.
Verified7Each opioid overdose death costs society $1.02 million on average.
Verified8Medicare spent $3.2 billion on opioid prescriptions in 2019.
Verified9Worker compensation claims for opioids cost $1.4 billion yearly.
Directional10Family members lost $25,000 income per opioid death due to caregiving.
Single source11Opioid epidemic reduced US GDP by 0.8% annually since 2015.
Verified12Neonatal abstinence syndrome cost $2.6 billion in hospitalizations 2014-2019.
Verified13Treatment for OUD costs $20,000-$50,000 per person annually untreated vs treated.
Verified14Illicit opioid market generated $150 billion revenue in US 2020 estimate.
Directional15Emergency department visits for opioids cost $11 billion in 2017.
Single source16Opioid prescriptions led to $78 billion in excess Medicare payments 2013-2017.
Verified17Suicide attempts from opioids cost $1.5 billion yearly.
Verified18Child welfare costs from parental opioid abuse: $8.2 billion in 2019.
Verified19Reduced labor force participation cost $50 billion annually.
Directional20Hospitalizations for OUD complications cost $15.7 billion in 2012.
Single sourceEconomic Costs Interpretation
We have tallied the bill for America's opioid crisis, and the invoice reads like a tragic comedy where every line item, from lost lives to stolen productivity, mocks the notion that this is anything less than a trillion-dollar wound upon the nation's soul.
Mortality and Overdoses
1In 2021, there were 80,411 drug overdose deaths involving opioids in the United States, a 22% increase from 2020.
Verified2Synthetic opioids other than methadone (primarily fentanyl) were involved in 71,238 overdose deaths in 2021, accounting for 88% of all opioid-involved overdose deaths.
Verified3From 1999 to 2021, nearly 645,000 people died from an overdose involving any opioid, including prescription and illicit opioids as well as heroin and fentanyl.
Verified4The age-adjusted rate of drug overdose deaths involving opioids increased from 14.6 per 100,000 in 2019 to 21.6 in 2021.
Directional5In 2022 provisional data, opioid-involved overdose deaths reached 81,806, with fentanyl implicated in 73,838 cases.
Single source6Heroin was involved in 9,413 overdose deaths in 2021, a decline from previous years due to shift to synthetics.
Verified7Methadone-involved overdose deaths totaled 5,327 in 2021.
Verified8Natural and semisynthetic opioids (like oxycodone) were linked to 16,416 deaths in 2021.
Verified9From 2015 to 2021, opioid overdose death rates among non-Hispanic Black persons increased by 59%, from 12.4 to 19.7 per 100,000.
Directional10Opioid overdose death rates for American Indian/Alaska Native persons rose 48% from 2019 to 2021.
Single sourceMortality and Overdoses Interpretation
This bleak arithmetic reveals a nation not just losing a battle against addiction, but being ambushed by a synthetic scourge, where a staggering 88% of opioid deaths are now fentanyl's handiwork, underscoring a crisis that has pivoted from the medicine cabinet to a poison pipeline.
Prevalence and Usage
1In 2019, 10.1 million people aged 12 or older misused prescription opioids in the past year in the US.
Verified2Past-year prescription opioid misuse among adults aged 18-25 was 3.8% in 2020, equating to 1.2 million people.
Verified3In 2021, 5.6 million people aged 12+ used prescription pain relievers for nonmedical purposes in the past year.
Verified4Heroin use in the past year among those 12+ was reported by 828,000 people in 2021.
Directional5Past-month illicit opioid use (heroin or misuse of prescription opioids) was 1.8% among adults 18+ in 2021.
Single source6In 2020, 9.3% of adults reported high-risk opioid prescription use per CDC guidelines.
Verified7Lifetime prescription opioid misuse prevalence was 35% among US adults in a 2019 survey.
Verified8Among high school seniors, 4% reported past-year misuse of opioids in 2021.
Verified9Opioid use disorder affected 2.7 million people aged 12+ in 2021.
Directional10Past-year pain reliever misuse initiated at age 12 or younger for 13% of misusers.
Single source11In 2021, 2.7% of pregnant women reported prescription opioid misuse during pregnancy.
Verified12Among US veterans, 11.5% had opioid use disorder in 2019.
Verified13Rural areas saw 17.3 opioid prescriptions per 100 persons vs 10.1 in urban in 2020.
Verified1416.3 million people received an opioid prescription in England in 2022.
Directional15Globally, 62 million people misused prescription opioids in 2019.
Single source16In Canada, 19% of adults reported lifetime prescription opioid use in 2019.
Verified17Opioid dispensing rates in Scotland fell 16% from 2019 to 2022.
Verified18In Australia, 1.1 million people misused pharmaceuticals including opioids in 2022.
Verified19Past-year opioid misuse among US adolescents (12-17) was 2.0% in 2021.
Directional2048.5% of opioid misusers also misused benzodiazepines in past year (2021).
Single source21In 2020, 16.9 million people aged 12+ used opioids in the past year in the US.
VerifiedPrevalence and Usage Interpretation
The sheer scale of these numbers, from millions of Americans to a startling lifetime prevalence of misuse, reveals an epidemic that is not a fringe crisis but a mainstream American tragedy woven into the fabric of communities from adolescence to adulthood.
Treatment and Recovery
1In 2020, only 13.5% of people with OUD received medications for OUD (MOUD).
Verified2Buprenorphine treatment retention averaged 50% at 6 months in 2021 studies.
Verified3Methadone maintenance reduced overdose risk by 59% per meta-analysis.
Verified4Naloxone distribution programs reduced overdose deaths by 46% in communities.
Directional5In 2021, 1.5 million people received substance use treatment for opioids.
Single source6MAT with buprenorphine increased 122% from 2017-2021.
Verified7Recovery rate from OUD is 40-60% with long-term treatment.
Verified890% of people with OUD do not receive any treatment annually.
Verified9Telehealth opioid treatment prescriptions rose 154% during COVID-19.
Directional10Contingency management boosted abstinence rates by 50% in trials.
Single source11Inpatient rehab completion rate for OUD is 58% at 90 days.
Verified12Naltrexone implant reduced relapse by 36% over 6 months.
Verified13Peer recovery coaching increased treatment engagement by 25%.
Verified14Polysubstance treatment success for opioids is 30% lower than single substance.
Directional151 in 4 patients on long-term opioids achieve sustained remission without meds.
Single source16Syringe service programs reduced HIV incidence by 50% among opioid users.
Verified17Buprenorphine initiation in EDs led to 67% linkage to ongoing care.
Verified18Long-acting naltrexone had 52% retention at 6 months vs 28% oral.
Verified19Family therapy improved adolescent OUD outcomes by 40%.
Directional20In 2022, 49 states expanded Medicaid to cover MOUD fully.
Single source21Chronic pain patients on opioids had 50% reduction in pain with CBT adjunct.
Verified22Relapse within 1 week post-detox is 40-60% without aftercare.
Verified23Housing first programs increased OUD treatment adherence by 30%.
Verified24In 2021, overdose deaths fell 8% in areas with high fentanyl test strip access.
Directional2570% of OUD patients in primary care achieved abstinence with integrated care.
Single sourceTreatment and Recovery Interpretation
It's frankly criminal that our most powerful weapons against this crisis—medication, wider access, and integrated support—are proving their worth in study after study, yet we still leave nine out of ten people fighting addiction utterly disarmed.
Sources & References
- Reference 1CDCcdc.govVisit source
- Reference 2NIDAnida.nih.govVisit source
- Reference 3SAMHSAsamhsa.govVisit source
- Reference 4JAMANETWORKjamanetwork.comVisit source
- Reference 5MONITORINGTHEFUTUREmonitoringthefuture.orgVisit source
- Reference 6DRUGABUSESTATISTICSdrugabusestatistics.orgVisit source
- Reference 7NCBIncbi.nlm.nih.govVisit source
- Reference 8GOVgov.ukVisit source
- Reference 9WHOwho.intVisit source
- Reference 10CANADAcanada.caVisit source
- Reference 11PUBLICHEALTHSCOTLANDpublichealthscotland.scotVisit source
- Reference 12AIHWaihw.gov.auVisit source
- Reference 13KFFkff.orgVisit source
- Reference 14VAva.govVisit source
- Reference 15BJSbjs.govVisit source
- Reference 16THETREVORPROJECTthetrevorproject.orgVisit source
- Reference 17HEALTHAFFAIRShealthaffairs.orgVisit source
- Reference 18ASIPPasipp.orgVisit source
- Reference 19BROOKINGSbrookings.eduVisit source
- Reference 20RANDrand.orgVisit source
- Reference 21OIGoig.hhs.govVisit source
- Reference 22ACFacf.hhs.govVisit source
- Reference 23COCHRANELIBRARYcochranelibrary.comVisit source
- Reference 24THELANCETthelancet.comVisit source
- Reference 25NEJMnejm.orgVisit source